JP2023538134A5 - - Google Patents
Info
- Publication number
- JP2023538134A5 JP2023538134A5 JP2023512710A JP2023512710A JP2023538134A5 JP 2023538134 A5 JP2023538134 A5 JP 2023538134A5 JP 2023512710 A JP2023512710 A JP 2023512710A JP 2023512710 A JP2023512710 A JP 2023512710A JP 2023538134 A5 JP2023538134 A5 JP 2023538134A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- linker
- compound
- target
- mannose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063068904P | 2020-08-21 | 2020-08-21 | |
| US63/068,904 | 2020-08-21 | ||
| PCT/US2021/046984 WO2022040580A1 (en) | 2020-08-21 | 2021-08-20 | Compositions and methods for targeting tumor-associated macrophages |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538134A JP2023538134A (ja) | 2023-09-06 |
| JP2023538134A5 true JP2023538134A5 (cg-RX-API-DMAC10.html) | 2024-08-27 |
Family
ID=80350585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512710A Pending JP2023538134A (ja) | 2020-08-21 | 2021-08-20 | 腫瘍関連マクロファージを標的とするための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240009314A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4199936A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023538134A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230058086A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116723846A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021327392A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3192041A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL300787A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023002038A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022040580A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024224138A1 (en) * | 2023-02-22 | 2025-08-14 | Resolute Science, Inc. | Compositions and methods for targeting tumor-associated macrophages |
| KR20250151447A (ko) * | 2023-02-22 | 2025-10-21 | 레졸루트 사이언스, 인크. | 종양-관련 대식세포를 표적화하기 위한 조성물 및 방법 |
| WO2024178142A1 (en) * | 2023-02-22 | 2024-08-29 | Resolute Science, Inc. | Compositions and methods for targeting tumor-associated macrophages |
| WO2024178140A1 (en) * | 2023-02-22 | 2024-08-29 | Resolute Science, Inc. | Compositions and methods for targeting tumor-associated macrophages |
| WO2025029126A1 (ko) * | 2023-08-03 | 2025-02-06 | 최종훈 | 산소가 담지된 나노리포좀 및 이의 용도 |
| CN117503760A (zh) * | 2023-10-20 | 2024-02-06 | 深圳大学 | 靶向kras g-四链体的吲哚类小分子在制备治疗三阴性乳腺癌药物中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6409990B1 (en) * | 1999-05-14 | 2002-06-25 | The Regents Of The University Of California | Macromolecular carrier for drug and diagnostic agent delivery |
| CA2955438C (en) * | 2014-07-17 | 2024-07-02 | Ohio State Innovation Foundation | DEXTRANE CONJUGATES TO TARGET MACROPHAGES AND OTHER CELLS EXPRESSING THE D-MANBOSE BINDING TYPE C LECTIN RECEPTOR |
| US20180021456A1 (en) * | 2015-02-04 | 2018-01-25 | University Of South Florida | Self-assembled targeted inclusion complexes for drug delivery |
| CN105343900B (zh) * | 2015-09-16 | 2019-04-02 | 中国海洋大学 | 褐藻多糖为载体的淋巴靶向核磁造影剂及制备方法和应用 |
| US20170333304A1 (en) * | 2016-05-20 | 2017-11-23 | Massachusetts Institute Of Technology | Hydrogel Particles, Compositions, and Methods |
| WO2018068060A1 (en) * | 2016-10-07 | 2018-04-12 | Navidea Biopharmaceuticals, Inc. | Compounds and methods for diagnosis and treatment of viral infections |
| TWI804499B (zh) * | 2017-06-23 | 2023-06-11 | 美商維洛斯生物公司 | Ror1抗體免疫接合物 |
| WO2019018815A1 (en) * | 2017-07-21 | 2019-01-24 | Navidea Biopharmaceuticals, Inc. | USE OF 99MTC-TILMANOCEPT AND ASSOCIATED MOLECULAR CONSTRUCTS FOR THE IDENTIFICATION AND DIAGNOSIS OF MALIGNANT TUMORS, AND FOR THE MONITORING OF ANTI-TUMOR THERAPEUTIC INTERVENTIONS |
| WO2020018434A1 (en) * | 2018-07-17 | 2020-01-23 | Scripps Health | Compositions and methods for disrupting a macrophage network |
| US20210052639A1 (en) * | 2019-08-19 | 2021-02-25 | Navidea Biopharmaceuticals, Inc. | Compositions and related methods for the ablation of m2 macrophages and myeloid derived suppressor cells |
| WO2021067479A1 (en) * | 2019-09-30 | 2021-04-08 | Navidea Biopharmaceuticals, Inc. | Compositions and related methods for blocking off-target localization of mannosylated dextrans and other cd206 ligands |
| US11859023B2 (en) * | 2020-07-08 | 2024-01-02 | Navidea Biopharmaceuticals, Inc. | Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof |
-
2021
- 2021-08-20 CA CA3192041A patent/CA3192041A1/en active Pending
- 2021-08-20 WO PCT/US2021/046984 patent/WO2022040580A1/en not_active Ceased
- 2021-08-20 JP JP2023512710A patent/JP2023538134A/ja active Pending
- 2021-08-20 IL IL300787A patent/IL300787A/en unknown
- 2021-08-20 AU AU2021327392A patent/AU2021327392A1/en active Pending
- 2021-08-20 MX MX2023002038A patent/MX2023002038A/es unknown
- 2021-08-20 EP EP21859232.7A patent/EP4199936A4/en active Pending
- 2021-08-20 KR KR1020237009697A patent/KR20230058086A/ko active Pending
- 2021-08-20 CN CN202180050960.7A patent/CN116723846A/zh active Pending
- 2021-08-20 US US18/022,095 patent/US20240009314A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6251477B2 (ja) | ヒト前立腺特異的膜抗原（ｐｓｍａ）をターゲッティングするｊ５９１ミニボディおよびｃｙｓダイアボディならびにこれらを使用するための方法 | |
| DE69423908T2 (de) | Antikörper gegen das carcinoembryonic antigen | |
| Rudd et al. | A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies | |
| Russell et al. | Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies | |
| Van Gog et al. | Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics | |
| Gupta et al. | 99mTc-methionine gold nanoparticles as a promising biomaterial for enhanced tumor imaging | |
| Kanazaki et al. | Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging | |
| Kim et al. | Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan | |
| Ediriweera et al. | Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery | |
| US20240009314A1 (en) | Compositions and methods for targeting tumor-associated macrophages | |
| Adumeau et al. | Site-specific, platform-based conjugation strategy for the synthesis of dual-labeled immunoconjugates for bimodal PET/NIRF imaging of HER2-positive tumors | |
| Jo et al. | Cancer therapy by antibody-targeted Cerenkov light and metabolism-selective photosensitization | |
| US6638508B2 (en) | Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system | |
| US20090098046A1 (en) | Combination Cancer Therapy with Anti-PSMA Antibodies | |
| Yao et al. | Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer | |
| JPH05500953A (ja) | 免疫共役体およびその代謝物の非標的保持量を減少させる方法 | |
| CN112111269B (zh) | 一种荧光和镥-177双标记生物分子及其制备方法与应用 | |
| WO2023048233A1 (ja) | 腫瘍細胞を死滅させるための医薬 | |
| US20070072251A1 (en) | In vivo imaging using peptide derivatives | |
| US20100179303A1 (en) | Site-specific conjugation of ligands to nanoparticles | |
| US11298431B2 (en) | Method for labeling radioisotope radiolabeling compound and kit comprising the same for labeling radioisotope | |
| Li et al. | A peptide nucleic acid-based pretargeting approach using 161Tb for radionuclide therapy in a murine tumor model | |
| Syrigos et al. | Use of monoclonal antibodies for the diagnosis and treatment of bladder cancer | |
| CN1315967A (zh) | 双功能抗体及其在导向抗肿瘤剂中的应用 | |
| US11497821B2 (en) | Method for labeling radioisotope, radiolabeling compounds using quinone compound and kit comprising the same for labeling radioisotope |